Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.58 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.46 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.44 |
| ▸ | PRKCG | P05129 | 1/20 | 0.44 |
| ▸ | PRKCB | P05771 | 1/20 | 0.44 |
| ▸ | PRKCA | P17252 | 1/20 | 0.44 |
| ▸ | PRKCH | P24723 | 1/20 | 0.44 |
| ▸ | PRKCI | P41743 | 1/20 | 0.44 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.44 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.44 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.44 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.44 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.44 |
| ▸ | ADH1B | P00325 | 1/20 | 0.43 |
| ▸ | ADH1C | P00326 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31509242 | 1.00 | ACE2 (0.58) | ACE2OPRM1LMNATSHRTHRB | |
| SCHEMBL652603 | 1.00 | ACE2 (0.58) | ACE2OPRM1LMNATSHRTHRB | |
| SCHEMBL3469393 | 1.00 | ACE2 (0.58) | ACE2OPRM1LMNATSHRTHRB | |
| SCHEMBL450698 | 1.00 | ACE2 (0.58) | ACE2OPRM1LMNATSHRTHRB | |
| SCHEMBL181032 | 1.00 | ACE2 (0.58) | ACE2OPRM1LMNATSHRTHRB | |
| SCHEMBL14484285 | 1.00 | ACE2 (0.58) | ACE2OPRM1LMNATSHRTHRB | |
| SCHEMBL19058823 | 1.00 | ACE2 (0.58) | ACE2OPRM1LMNATSHRTHRB | |
| SCHEMBL650705 | 1.00 | ACE2 (0.58) | ACE2OPRM1LMNATSHRTHRB | |
| SCHEMBL872663 | 1.00 | ACE2 (0.58) | ACE2OPRM1LMNATSHRTHRB | |
| SCHEMBL31509410 | 1.00 | ACE2 (0.58) | ACE2OPRM1LMNATSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102428169-B | Microbial Activity Improvement Agent, Microbial Activity Improvement Method, And Biological Waste Treatment Method | SUMITOMO HEAVY INDUSTRIES | 2014-05-07 | — | — | CN | claimed |
| WO-2008009680-A1 | NOVEL HYDROGEN-RICH 1,3-DIALKOXYDISILOXANES AND PROCESSES FOR THEIR PREPARATION AND THEIR USE | TECHNISCHE UNIVERSITÄT BERGAKADEMIE FREIBERG (DE) | 2008-01-24 | — | — | WO | claimed |
| JP-55104326-A | — | — | None | — | — | JP | disclosed |
| CN-120648508-A | Biological blended fuel | 常德坤亿新能源科技有限公司 | 2025-09-16 | — | — | CN | disclosed |
| US-20250197341-A1 | METHOD FOR INHIBITING CRYSTALLISATION | BIOSYNTHIS (FR) | 2025-06-19 | — | — | US | disclosed |
| EP-4387582-A1 | METHOD FOR INHIBITING CRYSTALLISATION | Biosynthis (FR) | 2024-06-26 | — | — | EP | disclosed |
| CN-117940101-A | Method for inhibiting crystallization | 碧昂赛恩斯公司 | 2024-04-26 | — | — | CN | disclosed |
| WO-2023020979-A1 | METHOD FOR INHIBITING CRYSTALLISATION | BIOSYNTHIS (FR) | 2023-02-23 | — | — | WO | disclosed |
| CN-214715682-U | Device for purifying a gas flow | 恩特格里斯公司 | 2021-11-16 | — | — | CN | disclosed |
| CN-112495141-A | Method and system for collecting tobacco fragrance in flue-cured tobacco leaf tail gas | 云南烟叶复烤有限责任公司 | 2021-03-16 | — | — | CN | disclosed |
| CN-111346505-A | Active wet type washing and filtering system | 恩特格里斯公司 | 2020-06-30 | — | — | CN | disclosed |
| US-6759254-B2 | System and method for determining and controlling contamination | EXTRACTION SYSTEMS, INC. | 2004-07-06 | — | — | US | disclosed |
| US-6746728-B1 | SUPERIOR LIQUID CRYSTALLINITY AND CO-SOLUBILITY WITH CURRENTLY USED LIQUID CRYSTAL COMPOUNDS; TEMPERATURE RANGE OVER WHICH LIQUID CRYSTALLINITY IS SHOWN IS BROAD; THRESHOLD VOLTAGE IS LOW; CAPABLE OF HIGH SPEED RESPONSE | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2004-06-08 | — | — | US | disclosed |
| EP-1201632-A1 | FUSED RING COMPOUND | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2002-05-02 | — | — | EP | disclosed |
| EP-1150606-A4 | A BREATH TEST FOR THE DETECTION OF VARIOUS DISEASES | PHILLIPS MICHAEL (US) | 2002-04-10 | — | — | EP | disclosed |
| EP-1191008-A1 | COMPOUND HAVING TETRAHYDRONAPHTHALENE SKELETON AND LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2002-03-27 | — | — | EP | disclosed |
| EP-1150606-A1 | A BREATH TEST FOR THE DETECTION OF VARIOUS DISEASES | Phillips, Michael (US) | 2001-11-07 | — | — | EP | disclosed |
| WO-2000041623-A9 | A BREATH TEST FOR THE DETECTION OF VARIOUS DISEASES | PHILLIPS MICHAEL (US) | 2001-06-14 | — | — | WO | disclosed |
| WO-2000041623-A1 | A BREATH TEST FOR THE DETECTION OF VARIOUS DISEASES | PHILLIPS MICHAEL (US) | 2000-07-20 | — | — | WO | disclosed |
| JP-S55104326-A | TREATMENT OF POLYAMIDE | ASAHI CHEM IND CO LTD | 1980-08-09 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250197341-A1 | METHOD FOR INHIBITING CRYSTALLISATION | FASN, SCD5, NFKB2 | ACE2 449/4885OPRM1 4200/4885LMNA 149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.